Related Experiment Videos
Phagocytic dysfunction in monocytes of normal newborn infants
Pediatrics
|March 1, 1980
Summary
Newborn monocytes exhibit slower phagocytosis than adult monocytes, a defect potentially linked to neonatal sepsis. Levamisole treatment normalized newborn monocyte phagocytic rates, suggesting a therapeutic avenue.
Area of Science:
- Immunology
- Neonatal Health
Background:
- Monocytes play a crucial role in the immune response.
- Phagocytosis is a key function of monocytes in pathogen clearance.
- Neonatal immune system immaturity can increase susceptibility to infections.
Purpose of the Study:
- To compare the phagocytic kinetics of monocytes from newborns and adults.
- To investigate the effect of levamisole on monocyte phagocytosis in neonates.
Main Methods:
- Isolation of monocytes from cord blood and adult volunteers.
- Incubation of monocytes with polystyrene spheres to quantify phagocytosis.
- Assessment of phagocytic rates over 120 minutes.
- Evaluation of levamisole's impact on phagocytosis.
Main Results:
- Neonatal monocytes demonstrated significantly slower phagocytosis rates compared to adult monocytes.
- While initially slower, all neonatal monocytes eventually engulfed particles.
- Levamisole accelerated phagocytosis in neonatal monocytes to adult levels.
- Levamisole had no effect on adult monocyte phagocytosis.
Conclusions:
- Neonatal monocytes have impaired early-stage phagocytic efficiency.
- This phagocytic defect may contribute to the risk of neonatal sepsis.
- Levamisole shows potential for modulating neonatal monocyte function.